Author Correction: The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

Ezra Y Rosen; Helen H Won; Youyun Zheng; Emiliano Cocco; Duygu Selcuklu; Yixiao Gong; Noah D Friedman; Ino de Bruijn; Onur Sumer; Craig M Bielski; Casey Savin; Caitlin Bourque; Christina Falcon; Nikeysha Clarke; Xiaohong Jing; Fanli Meng; Catherine Zimel; Sophie Shifman; Srushti Kittane; Fan Wu; Marc Ladanyi; Kevin Ebata; Jennifer Kherani; Barbara J Brandhuber; James Fagin; Eric J Sherman; Natasha Rekhtman; Michael F Berger; Maurizio Scaltriti; David M Hyman; Barry S Taylor; Alexander Drilon

doi:10.1038/s41467-022-29700-y

Author Correction: The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

Nat Commun. 2022 Apr 5;13(1):1936. doi: 10.1038/s41467-022-29700-y.

Authors

Ezra Y Rosen^#¹, Helen H Won^#^{2

3}, Youyun Zheng⁴, Emiliano Cocco^{5

6}, Duygu Selcuklu², Yixiao Gong², Noah D Friedman^{5

7}, Ino de Bruijn², Onur Sumer², Craig M Bielski^{5

7

8}, Casey Savin², Caitlin Bourque², Christina Falcon¹, Nikeysha Clarke¹, Xiaohong Jing², Fanli Meng², Catherine Zimel², Sophie Shifman⁴, Srushti Kittane⁴, Fan Wu⁴, Marc Ladanyi⁴, Kevin Ebata³, Jennifer Kherani³, Barbara J Brandhuber³, James Fagin¹, Eric J Sherman¹, Natasha Rekhtman⁴, Michael F Berger^{2

4

8}, Maurizio Scaltriti^{5

9}, David M Hyman³, Barry S Taylor^#^{10

11

12

13

14}, Alexander Drilon^#¹⁵

Affiliations

¹ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
³ Loxo Oncology at Lilly, Stamford, CT, USA.
⁴ Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁵ Department of Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁶ University of Miami, Miller School of Medicine, Department of Biochemistry and Molecular Biology/Sylvester Comprehensive Cancer Center, Miami, FL, USA.
⁷ Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁸ Weill Cornell Medical College, New York, NY, USA.
⁹ AstraZeneca, Waltham, MA, USA.
¹⁰ Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. taylor.lab.msk@gmail.com.
¹¹ Department of Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. taylor.lab.msk@gmail.com.
¹² Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. taylor.lab.msk@gmail.com.
¹³ Weill Cornell Medical College, New York, NY, USA. taylor.lab.msk@gmail.com.
¹⁴ Loxo Oncology at Lilly, Stamford, CT, USA. taylor.lab.msk@gmail.com.
¹⁵ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. drilona@mskcc.org.

^# Contributed equally.

No abstract available

Publication types

Published Erratum

Grants and funding

P30 CA008748/CA/NCI NIH HHS/United States